Voyager Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Voyager Therapeutics

12/11/2024 23:16

* Voyager Therapeutics Inc  VYGR.OQ  reported a quarterly
adjusted
loss of 16 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -59 cents.  The mean expectation of ten analysts
for the quarter was for a loss of 45 cents per share. Wall
Street expected results to range from -65 cents to -8 cents per
share.
    * Revenue rose 433.8% to $24.63 million from a year ago;
analysts
expected $11.89 million. 
    * Voyager Therapeutics Inc's reported EPS for the quarter
was a
loss of 16 cents​.
    * The company reported a quarterly loss of $9.04 million.
    * Voyager Therapeutics Inc shares had risen by 19.8% this
quarter and lost 16.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 12.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Voyager
Therapeutics Inc is 18.00 
This summary was machine generated from LSEG data November 12 at
11:16 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.45          -0.16          Beat
 Jun. 30 2024      -0.41          -0.18          Beat
 Mar. 31 2024      -0.44          -0.20          Beat
 Dec. 31 2023      -0.29          1.25           Beat